Precipio, Inc.(PRPO)Stock Analysis

Quirks, history, and lore behind PRPO — the kind of stuff that makes a stock memorable.

• 1
  The Basics

  A small-cap U.S. healthcare technology company listed on Nasdaq, headquartered in Connecticut, focused on the intersection of diagnostics and data.
• 2
  The Numbers

  Annual revenue in the low tens of millions of dollars — firmly micro-cap territory — with a history of operating losses as it scales its lab network.
• 3
  The History

  Founded in the 2010s, the company was built around the idea that community hospitals and clinics deserved access to the same advanced cancer diagnostics typically reserved for big academic medical centers.
• 4
  The Secret

  Its model pairs proprietary diagnostic testing with an analytics platform, aiming to catch misdiagnosed cancers — a problem it argues is far more common than the industry admits.
• 5
  The Lore

  The company has leaned heavily on the argument that up to 30% of cancer diagnoses contain errors, using that statistic as both a mission statement and a sales pitch to hospital partners.
• 6
  The Giveaway

  Its ticker is four letters starting with PR, its name sounds like it means "rushing forward," and it runs CLIA-certified labs specializing in hematology and oncology pathology.